5 Best Stocks Under $20 According to Billionaire Andreas Halvorsen’s Viking Global

4. Inhibrx, Inc. (NASDAQ:INBX)

Viking Global’s Stake Value: $231.7 million

Percentage of Viking Global’s 13F Portfolio: 0.67%

Number of Hedge Fund Holders: 14

Share Price on April 26, 2022: $15.40

Inhibrx, Inc. (NASDAQ:INBX) is a biotechnology company based in La Jolla, California, United States. It develops treatments for several kinds of cancers, solid tumors, and deficiencies.

By the end of its fiscal Q4, Inhibrx, Inc. (NASDAQ:INBX) reported $2.86 million in revenue and -$0.55 in GAAP EPS, for a strong set of results that saw the company beat analyst estimates for both. SMBC Nikko set a $40 price target for the company in March 2022, stating that it is developing promising treatments.

Viking Global owned 5.3 million Inhibrx, Inc. (NASDAQ:INBX) shares by the end of last year’s fourth quarter. This resulted in it having a $231 million stake that represented 0.67% of its investment portfolio. Insider Monkey surveyed 924 hedge funds for the same time period to discover that 14 had also bought the company’s shares.

Inhibrx, Inc. (NASDAQ:INBX)’s largest investor after Viking Global is Joseph Edelman’s Perceptive Advisors which owns 1.3 million shares that are worth $58 million.